{"id":"https://openalex.org/W3096209544","doi":"https://doi.org/10.1182/blood-2020-139340","title":"The Genomic and Transcriptomic Landscape of Plasma Cell Leukemia","display_name":"The Genomic and Transcriptomic Landscape of Plasma Cell Leukemia","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3096209544","doi":"https://doi.org/10.1182/blood-2020-139340","mag":"3096209544"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-139340","doi":"https://doi.org/10.1182/blood-2020-139340","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-139340","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034519944","display_name":"Titouan Cazaubiel","orcid":"https://orcid.org/0009-0007-5834-5318","observed_orcids":["https://orcid.org/0009-0007-5834-5318"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Titouan Cazaubiel","raw_affiliation_strings":["Service d'h\u00e9matologie, H\u00f4pital Haut L\u00e9v\u00eaque, CHU Bordeaux, Bordeaux, France","Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'h\u00e9matologie, H\u00f4pital Haut L\u00e9v\u00eaque, CHU Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079686050","display_name":"Laure Buisson","orcid":"https://orcid.org/0000-0002-6110-4781","observed_orcids":["https://orcid.org/0000-0002-6110-4781"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laure Buisson","raw_affiliation_strings":["Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081357051","display_name":"Sabrina Mah\u00e9o","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sabrina Maheo","raw_affiliation_strings":["Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015800894","display_name":"Laura Do Souto","orcid":"https://orcid.org/0000-0003-1038-3458","observed_orcids":["https://orcid.org/0000-0003-1038-3458"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laura Do Souto Ferreira","raw_affiliation_strings":["Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000240846","display_name":"Romain Lannes","orcid":"https://orcid.org/0000-0002-6672-1762","observed_orcids":["https://orcid.org/0000-0002-6672-1762"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Romain Lannes","raw_affiliation_strings":["Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082698003","display_name":"Aurore Perrot","orcid":"https://orcid.org/0000-0003-0131-8689","observed_orcids":["https://orcid.org/0000-0003-0131-8689"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurore Perrot","raw_affiliation_strings":["Service d'H\u00e9matologie, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'H\u00e9matologie, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089853890","display_name":"Cyrille Hulin","orcid":"https://orcid.org/0000-0002-3749-5161","observed_orcids":["https://orcid.org/0000-0002-3749-5161"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cyrille Hulin","raw_affiliation_strings":["Service d'h\u00e9matologie, H\u00f4pital Haut L\u00e9v\u00eaque, CHU Bordeaux, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'h\u00e9matologie, H\u00f4pital Haut L\u00e9v\u00eaque, CHU Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Avet-Loiseau","raw_affiliation_strings":["Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030565933","display_name":"Jill Corre","orcid":"https://orcid.org/0000-0003-1580-6106","observed_orcids":["https://orcid.org/0000-0003-1580-6106"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jill Corre","raw_affiliation_strings":["Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 de G\u00e9nomique du My\u00e9lome, IUCT- Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.9998,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.77330489,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"48","last_page":"49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-plasma-cell-leukemia","display_name":"primary plasma cell leukemia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/genomic-profiling","display_name":"genomic profiling","score":0.3840000033378601},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.9100000262260437},{"id":"https://openalex.org/keywords/igh-translocation","display_name":"IGH translocation","score":0.7599999904632568},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7350000143051147},{"id":"https://openalex.org/keywords/myd88-mutation","display_name":"MYD88 mutation","score":0.47699999809265137},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.5389999747276306},{"id":"https://openalex.org/keywords/1q-gain","display_name":"1q gain","score":0.7549999952316284},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hyperdiploidy","display_name":"hyperdiploidy","score":0.671999990940094},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.675000011920929},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6729999780654907},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2780353925","wikidata":"https://www.wikidata.org/wiki/Q7201765","display_name":"Plasma cell leukemia","level":3,"score":0.7810168266296387},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.5095512866973877},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4904775321483612},{"id":"https://openalex.org/C84597430","wikidata":"https://www.wikidata.org/wiki/Q106227","display_name":"Locus (genetics)","level":3,"score":0.43976473808288574},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.428066223859787},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3872388005256653},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3710108995437622},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.3567514717578888},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3394567370414734},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32543784379959106},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19022992253303528},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.18842560052871704}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-139340","doi":"https://doi.org/10.1182/blood-2020-139340","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-139340","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4212913573","https://openalex.org/W2912131927","https://openalex.org/W7108465524","https://openalex.org/W2086442724","https://openalex.org/W2584000495","https://openalex.org/W2924686853","https://openalex.org/W2944795805","https://openalex.org/W3036479848","https://openalex.org/W3203537902","https://openalex.org/W4220801094"],"abstract_inverted_index":{"Background:":[0],"Primary":[1],"plasma":[2,99],"cell":[3],"leukemia":[4],"(pPCL)":[5],"is":[6,39],"a":[7,53,87,92,183,206,397,424,438,521,578],"rare":[8],"and":[9,21,24,32,62,72,74,91,114,133,163,169,176,228,263,284,324,347,363,384,417,434,437,449,458,486,491,501,511,528,568,587,598,604,636],"aggressive":[10,600],"form":[11],"of":[12,28,52,56,65,95,105,123,139,187,209,222,238,278,306,318,330,367,401,407,428,442,477,503,515,556,571,585,602,608],"multiple":[13],"myeloma":[14],"(MM)":[15],"with":[16,110,121,137,171,198,219,302,314,346,357,457,484,497,505,520,558,582,619],"an":[17,235,303],"extremely":[18],"poor":[19],"prognosis":[20],"distinct":[22,413,463],"biological":[23,35],"clinical":[25,78,172],"features.":[26,590],"Because":[27],"its":[29,33,46],"low":[30],"incidence":[31,237],"heterogeneity,":[34,575],"knowledge":[36],"about":[37],"pPCL":[38,57,111,196,218,244,297,345,356,370,416,456,496,506,576,603,618],"lacking":[40],"especially":[41],"molecular":[42],"process":[43],"responsible":[44],"for":[45,468,542,617],"aggressiveness.":[47],"Here,":[48],"we":[49,85,350,548],"took":[50],"advantage":[51],"large":[54],"series":[55,555],"to":[58,67,75,594],"describe":[59],"the":[60,103,146,212,270,328,472,478,534,538,550,553,599,606],"genomic":[61,119,185,300,342,567,589],"transcriptomic":[63,135,464,569],"landscape":[64,400,570,581],"pPCL,":[66],"identify":[68],"potential":[69],"driver":[70],"mutations":[71,277,362,517],"pathways,":[73],"determine":[76],"their":[77,118,134,574],"impacts.":[79],"Methods:":[80],"To":[81,545],"address":[82],"these":[83],"issues,":[84],"performed":[86],"targeted":[88],"DNA":[89],"sequencing":[90,94],"RNA":[93],"sorted":[96],"bone":[97],"marrow":[98],"cells":[100],"collected":[101],"at":[102,126,142,509],"time":[104],"diagnosis":[106,127,143],"from":[107,145,344],"96":[108],"patients":[109,504,557],"between":[112,415],"2014":[113],"2020.":[115],"We":[116,204],"compared":[117,197],"profiles":[120,136,309,343,410],"those":[122,138],"907":[124],"MM":[125,141,199],"previously":[128],"obtained":[129,144],"in":[130,195,217,275,294,431,445,466,471,495],"our":[131,546],"laboratory":[132],"300":[140],"IFM2009/DFCI":[147],"trial":[148],"(NCT01191060).":[149],"Copy":[150],"number":[151],"aberrations":[152],"(CNA),":[153],"single":[154],"nucleotide":[155],"variants":[156],"(SNV),":[157],"translocations,":[158],"mutations,":[159],"gene":[160,164,408],"expression":[161,409,427,441],"(GE)":[162],"set":[165,420],"enrichment":[166,421],"were":[167,192,290,481,507],"analyzed":[168],"correlated":[170],"information":[173,564],"(overall":[174],"survival":[175],"progression-free":[177],"survival).":[178],"Results:":[179],"Genome":[180],"analysis":[181,394,422],"highlighted":[182],"specific":[184,398,579],"profile":[186],"pPCL.":[188,295,402,559,572],"Indeed,":[189,403],"hyperdiploid":[190],"karyotypes":[191],"less":[193],"frequent":[194,293],"(20%":[200],"vs":[201,225,231,241,254,260,266,281,287,311,321,336],"57%,":[202],"p<0,001).":[203,268],"found":[205,351],"high":[207,583],"prevalence":[208,584],"translocations":[210,536],"involving":[211],"heavy":[213],"chain":[214],"locus":[215],"(IGH)":[216],"higher":[220,426],"incidences":[221],"t(11;14)":[223,349,358,372,460,586],"(51%":[224],"23%,":[226],"p<0,001)":[227,262,283,313,323],"t(14;16)":[229],"(14%":[230],"3%,":[232,322],"p<0,001),":[233,256],"but":[234],"identical":[236],"t(4;14)":[239],"(11%":[240,286,335],"10%,":[242],"p=0,7).":[243],"presented":[245,298,461],"more":[246,292,315,325,360,364,374],"adverse":[247,375],"cytogenetic":[248,376],"abnormalities":[249,377],"such":[250,378,612],"as":[251,379,613],"del(17p)":[252],"(30%":[253],"9,5%,":[255],"1q":[257,382],"gain":[258],"(53%":[259],"32%,":[261],"del(1p32)":[264],"(24%":[265],"9%,":[267],"Among":[269],"246":[271],"recurrently":[272],"mutated":[273],"genes":[274,429,443,469],"MM,":[276],"TP53":[279,319,361,516],"(21%":[280],"5%,":[282,312,337],"IRF4":[285],"4%,":[288],"p<0,005)":[289],"significantly":[291,425,439,489,493,522],"Furthermore,":[296,455],"high-risk":[299,588],"features":[301],"increased":[304],"proportion":[305],"Double":[307],"Hit":[308],"(27%":[310],"bi-allelic":[316,365],"inactivation":[317,366],"(17%":[320],"amp1q":[326],"on":[327,552,565],"background":[329],"International":[331],"Staging":[332],"System":[333],"III":[334],"p<0,005).":[338],"Interestingly,":[339],"by":[340],"comparing":[341],"without":[348,371,459],"two":[352,389,412,462],"distinctive":[353,390],"patterns.":[354],"Indeed":[355],"showed":[359,373,395],"TP53.":[368],"While":[369],"trisomy":[380],"21,":[381],"gains":[383],"del(1p32).":[385],"These":[386,591],"results":[387,561,592],"suggest":[388],"oncogenic":[391],"mechanisms.":[392],"RNA-seq":[393],"also":[396],"transcriptional":[399],"unsupervised":[404],"hierarchical":[405],"clustering":[406],"demonstrated":[411],"clusters":[414],"MM.":[418],"Gene":[419],"identified":[423],"involved":[430,444],"MYC":[432],"Targets":[433],"G2M":[435],"checkpoint,":[436],"lower":[440,523],"P53":[446],"pathway,":[447],"hypoxia":[448],"TNF":[450],"alpha":[451],"signaling":[452],"via":[453],"NF-\u03baB.":[454],"patterns,":[465],"particular":[467],"implicated":[470],"apoptotic":[473],"machinery.":[474],"Three":[475],"members":[476],"BCL2":[479,485,614],"family":[480],"differentially":[482],"expressed":[483],"PMAIP1":[487],"[NOXA]":[488],"overexpressed":[490],"BCL2L1":[492],"underexpressed":[494],"t(11;14).":[498,620],"Median":[499],"PFS":[500,524],"OS":[502,529],"respectively":[508],"11":[510],"15":[512],"months.":[513],"Presence":[514],"was":[518],"associated":[519],"(4":[525],"months,":[526,531],"p<0,05)":[527],"(5":[530],"p<0,05).":[532],"Neither":[533],"IgH":[535],"nor":[537],"ploidy":[539],"status":[540],"predicted":[541],"survival.":[543],"Conclusion:":[544],"knowledge,":[547],"present":[549,577],"study":[551],"largest":[554],"Our":[560],"provide":[562],"new":[563,609],"both":[566],"Despite":[573],"mutational":[580],"help":[593],"better":[595],"understand":[596],"oncogenicity":[597],"behavior":[601],"support":[605],"use":[607],"treatment":[610],"strategies":[611],"inhibitor":[615],"(Venetoclax)":[616],"Disclosures":[621],"Perrot:":[622],"Amgen,":[623],"BMS/Celgene,":[624],"Janssen,":[625,634],"Sanofi,":[626],"Takeda:":[627,637],"Consultancy,":[628],"Honoraria,":[629],"Research":[630],"Funding.":[631],"Hulin:Celgene/Bristol-Myers":[632],"Squibb,":[633],"GlaxoSmithKline,":[635],"Honoraria.":[638]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-11-09T00:00:00"}